UK markets closed

Thinkific Labs Inc. (THNC.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
3.7200+0.0200 (+0.54%)
At close: 03:57PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 251.84M
Enterprise value 133.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.61
Price/book (mrq)2.34
Enterprise value/revenue 1.60
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.65
52-week change 387.56%
S&P500 52-week change 323.20%
52-week high 34.3000
52-week low 31.6000
50-day moving average 33.6015
200-day moving average 33.2188

Share statistics

Avg vol (3-month) 331.3k
Avg vol (10-day) 326.72k
Shares outstanding 523.75M
Implied shares outstanding 6162.1M
Float 823.59M
% held by insiders 10.43%
% held by institutions 130.00%
Shares short (14 Jun 2024) 44.87k
Short ratio (14 Jun 2024) 40.68
Short % of float (14 Jun 2024) 4N/A
Short % of shares outstanding (14 Jun 2024) 40.02%
Shares short (prior month 15 May 2024) 421.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -6.31%
Operating margin (ttm)-9.63%

Management effectiveness

Return on assets (ttm)-4.83%
Return on equity (ttm)-4.79%

Income statement

Revenue (ttm)60.93M
Revenue per share (ttm)0.75
Quarterly revenue growth (yoy)13.30%
Gross profit (ttm)N/A
EBITDA -7.05M
Net income avi to common (ttm)-3.84M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)87.31M
Total cash per share (mrq)1.08
Total debt (mrq)875k
Total debt/equity (mrq)1.11%
Current ratio (mrq)5.29
Book value per share (mrq)0.97

Cash flow statement

Operating cash flow (ttm)3M
Levered free cash flow (ttm)3.7M